Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.77
|
0.84
|
0.771
|
0.771
|
0.801899
|
0.801899
|
|
|
660.55
|
14.00
|
0.7901
|
0.8545
|
0.7998
|
0.771
|
0.80
|
0.79
|
|
|
5 381.55
|
18.00
|
0.7898
|
0.8483
|
0.8198
|
0.78
|
0.8198
|
0.79
|
|
|
2 399.69
|
35.00
|
0.76
|
0.8199
|
0.7909
|
0.757
|
0.8111
|
0.81
|
|
|
1 418.15
|
28.00
|
0.78
|
0.96
|
0.77
|
0.77
|
0.8298
|
0.7909
|
|
|
1 378.80
|
39.00
|
0.76
|
0.80
|
0.885
|
0.7351
|
0.885
|
0.761
|
|
|
7 577.46
|
74.00
|
0.8303
|
1.04
|
0.89
|
0.868
|
0.89
|
0.885
|
|
|
1 648.48
|
26.00
|
0.86
|
1.01
|
0.9148
|
0.88105
|
0.9148
|
0.88105
|
|
|
617.41
|
20.00
|
0.931
|
1.01
|
0.8709
|
0.8307
|
0.92
|
0.92
|
|
|
1 801.82
|
47.00
|
0.8707
|
1.03
|
1.00
|
0.8775
|
1.00
|
0.8775
|
|
|
8 092.62
|
45.00
|
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.